Kenny Lim
Nov 26, 2008

Bates141 bags Merck business in Indonesia

JAKARTA - Global pharmaceutical firm Merck has appointed Bates141 for its estimated US$2 million creative business in Indonesia to develop communications for its portfolio of products in 2009.

Bates141 bags Merck business in Indonesia
The WPP firm bagged the account following strategy and creative presentations and has been tasked with repositioning vitamin supplements including Neurobion and Sangobion, which are popular over the counter brands, to a wider audience in Indonesia.

Other products in Bates’s remit include Becombion and Seven Seas. Merck had previously worked with DDB.

There are currently 29 international pharmaceutical companies marketing their products in Indonesia’s $2 billion pharmaceutical industry. Indonesian authorities have also recently imposed a ruling that requires foreign drug companies to establish local production facilities.

Related Articles

Just Published

5 hours ago

How can AI be leveraged in community engagement?

At IAB's recent event in Hong Kong, panellists from Meta, Netflix, 9Gag, and Xiaohongshu debate the many pros and cons of AI to connect with its communities.

5 hours ago

Is advertising still a viable career for young people?

Campaign explores how an industry reliant on new blood to remain current will need to adapt to appeal to the younger talent it wants.

5 hours ago

The rise of the knowledge athlete

Why creativity not productivity will define the competitive edge, and how professionals are training themselves for an advantage.

7 hours ago

Move and win roundup: Week of September 30, 2024

IPG, The Guardian, Skyscanner and more, in our weekly roundup of people moves and account wins.